Par Drugs and Chemicals Limited

NSE:PAR.NS

95.99 (INR) • At close July 4, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 223.298213.811346.569226.056228.192239.991258.873229.347238.379229.327248.18235.065212.064169.155195.948164.834153.408162.719141.336141.336133.686133.686145.557145.557107.309107.309124.308124.308
Kosten van de omzet 97.77488.085143.2674.86199.264101.517110.239116.247349.154102.592104.247108.057304.58464.91968.12861.006206.92761.47752.98452.98459.92359.92361.60361.60342.0442.0454.06754.067
Brutowinst 125.524125.726203.309151.195128.928138.474148.634113.1-110.775126.735143.933127.008-92.52104.236127.82103.828-53.519101.24288.35388.35373.76373.76383.95583.95565.26865.26870.24170.241
Brutowinstmarge 0.5620.5880.5870.6690.5650.5770.5740.493-0.4650.5530.580.54-0.4360.6160.6520.63-0.3490.6220.6250.6250.5520.5520.5770.5770.6080.6080.5650.565
Onderzoek- en ontwikkelingskosten 000000002.7750001.2170000.9880000.3330.333000.2720.27200
Algemene en administratieve kosten 0000000000000000000000000000
Verkoop- en marketingkosten 0000000000000000000000000000
Verkoop-, algemene en administratieve kosten 19.101098.30812.61776.90894.83783.48780.0915.57513.39374.54680.54669.10258.37777.76753.70812.0210.3858.698.6910.36810.36810.210.27.9167.91610.55910.559
Overige kosten 0120.5790117.883-0.482.2910.4910.12100.3770.15897.419-125.8850.5180.2770.374-0.3460.3110000000000
Bedrijfskosten 19.101120.57998.308117.88376.90894.83783.48780.09-151.905101.85394.01397.419-125.88576.38195.72270.594-88.9668.43456.39656.39652.95552.95571.33571.33556.36456.36454.99954.999
Bedrijfsresultaat 106.4235.147105.00133.31252.0243.63765.14733.0145.34924.88250.07931.12336.45428.37332.37533.60736.33333.11931.68531.68520.82420.82412.61212.6129.7199.71915.91215.912
Bedrijfsresultaat ratio 0.4770.0240.3030.1470.2280.1820.2520.1440.190.1090.2020.1320.1720.1680.1650.2040.2370.2040.2240.2240.1560.1560.0870.0870.0910.0910.1280.128
Totaal overige inkomsten en kosten netto -83.6362.5779.8680.538-0.9312.0950.224-0.0360.0450.082-0.1411.0672.918-0.472-2.0050.03918.633-0.179-1.406-1.406-1.389-1.389-2.088-2.088-51.089-51.089-5.72-5.72
Inkomen voor belasting 22.7877.724114.86933.8551.08945.73265.37132.97445.39424.96449.77930.65636.28327.38330.09333.27354.07432.62930.27930.27919.43519.43510.52410.5245.9915.99110.19210.192
Inkomen voor belasting ratio 0.1020.0360.3310.150.2240.1910.2530.1440.190.1090.2010.130.1710.1620.1540.2020.3520.2010.2140.2140.1450.1450.0720.0720.0560.0560.0820.082
Belastingkosten 6.2771.94428.918.51913.89511.5116.4538.29910.9246.28312.5287.71512.0416.237.898.729.90211.7984.7254.7253.5533.5532.5812.5813.9033.9033.3543.354
Nettowinst 16.515.7885.95825.33137.19434.22248.91824.67534.4718.6837.25122.9424.24221.15322.20324.55344.17220.83125.55525.55515.88215.8827.9437.9432.0882.0886.8396.839
Nettowinstmarge 0.0740.0270.2480.1120.1630.1430.1890.1080.1450.0810.150.0980.1140.1250.1130.1490.2880.1280.1810.1810.1190.1190.0550.0550.0190.0190.0550.055
WPA (Winst Per Aandeel) 1.340.476.992.063.022.783.982.012.81.523.031.861.971.721.823.593.392.082.081.291.290.650.650.170.171.271.27
Verwaterde WPA 1.340.476.992.063.022.783.982.012.81.523.031.861.971.721.823.593.392.082.081.291.290.650.650.170.171.271.27
EBITDA 24.19917.009124.24543.08460.00854.58174.11641.44254.14332.68459.20538.42345.88836.1240.72441.65363.51939.32839.04639.04621.15421.15426.08926.08918.27418.27422.54222.542
EBITDA ratio 0.1080.080.3590.1910.2630.2270.2860.1810.2270.1430.2390.1630.2160.2140.2080.2530.4140.2420.2760.2760.1580.1580.1790.1790.170.170.1810.181